首页> 中国专利> 凝血酶抗体、其抗原结合片段及医药用途

凝血酶抗体、其抗原结合片段及医药用途

页面导航

摘要
著录项
法律信息
相似文献

摘要

本公开涉及凝血酶抗体、其抗原结合片段及医药用途。进一步地，本公开涉及包含所述凝血酶抗体CDR区的鼠源抗体、嵌合抗体、人源化抗体，以及包含凝血酶抗体和/或其抗原结合片段的药物组合物，以及其作为药物的用途。特别地，本公开涉及一种人源化的凝血酶抗体在制备用于治疗凝血酶相关的疾病或病症的药物中的用途。

著录项

公开/公告号CN111094354A

专利类型发明专利
公开/公告日2020-05-01

原文格式PDF
申请/专利权人江苏恒瑞医药股份有限公司;上海恒瑞医药有限公司;
展开▼

申请/专利号CN201880059071.5
发明设计人应华;毛浪勇;孙嘉康;胡齐悦;陶维康;
展开▼

申请日2018-11-19
分类号
代理机构北京戈程知识产权代理有限公司;
代理人程伟
地址 222047 江苏省连云港市经济技术开发区昆仑山路7号
入库时间 2023-12-17 08:34:24

法律信息

法律状态公告日

法律状态信息

法律状态
2020-05-29

实质审查的生效 IPC(主分类):C07K16/40 申请日:20181119

实质审查的生效
2020-05-01

公开

公开

相似文献

专利
中文文献
外文文献

1. 凝血酶抗体、其抗原结合片段及医药用途 [P] . 中国专利： CN107043423B . 2021.02.26
2. 凝血酶抗体、其抗原结合片段及医药用途 [P] . 中国专利： CN111094354A . 2020-05-01
3. anti-human sirpa antibody or antigen-binding fragment thereof or antigen-binding antibody mimetic, pharmaceutical composition, combination product, isolated nucleic acid molecule, vector, isolated host cell, polypeptide, methods for making an antibody, in in vitro or ex vivo to determine sirp positive, diagnostic and predictive response cells of a subject, and use of an anti-sirp antibody or antigen-binding fragment thereof or an antibody-binding mimetic in vitro or ex vivo of at least one anti-human sirpa antibody or antigen binding fragment thereof or antigen binding antibody mimetic. [P] . BR112018070823A2 . 2019-02-05

机译：抗人Sirpa抗体或其抗原结合片段或抗原结合抗体模拟物，药物组合物，联合产品，分离的核酸分子，载体，分离的宿主细胞，多肽，在体外或离体制备抗体的方法确定受试者的sirp阳性，诊断和预测反应细胞，以及至少一种抗人sirpa抗体或抗原结合的体外或离体的抗sirp抗体或其抗原结合片段或抗体结合模拟物的用途其片段或抗原结合抗体模拟物。
4. isolated monoclonal antibodies; monoclonal antibodies or antigen binding fragments thereof; composition; isolated polynucleotide molecules; recombinant polypeptide; polypeptides; host cell; method of making an antibody; use of an agent for treating cancer in a patient; uses of monoclonal antibody or antigen-binding fragment thereof for the treatment of a subject suffering from cancer; use of monoclonal antibody to treat a subject suffering from cancer; a composition comprising an agr2 binding antibody; a composition comprising a c4.4a binding antibody; a composition comprising an agr2 binding antibody and a c4.4a binding antibody; composition comprising an antibody; use of an agr2 binding antibody; use of a c4.4a binding antibody; use of an antibody; and kit comprising an antibody [P] . BR112017004510A2 . 2018-01-23

机译：分离的单克隆抗体;单克隆抗体或其抗原结合片段;组成;分离的多核苷酸分子;重组多肽多肽;宿主细胞;制备抗体的方法;药剂用于治疗患者的癌症的用途;单克隆抗体或其抗原结合片段在治疗癌症患者中的用途;单克隆抗体在治疗患有癌症的受试者中的用途;包含agr2结合抗体的组合物;包含c4.4a结合抗体的组合物;包含agr2结合抗体和c4.4a结合抗体的组合物;包含抗体的组合物;使用agr2结合抗体;使用c4.4a结合抗体;抗体的使用;和包含抗体的试剂盒
5. isolated monoclonal antibodies; monoclonal antibodies or antigen binding fragments thereof; composition; isolated polynucleotide molecules; recombinant polypeptide; polypeptides; host cell; method of making an antibody; use of an agent for treating cancer in a patient; uses of monoclonal antibody or antigen-binding fragment thereof for the treatment of a subject suffering from cancer; use of monoclonal antibody to treat a subject suffering from cancer; a composition comprising an agr2 binding antibody; a composition comprising a c4.4a binding antibody; a composition comprising an agr2 binding antibody and a c4.4a binding antibody; composition comprising an antibody; use of an agr2 binding antibody; use of a c4.4a binding antibody; use of an antibody; and kit comprising an antibody [P] . BR112017004510A8 . 2018-06-26

机译：分离的单克隆抗体;单克隆抗体或其抗原结合片段;组成;分离的多核苷酸分子;重组多肽多肽;宿主细胞;制备抗体的方法;药剂用于治疗患者的癌症的用途;单克隆抗体或其抗原结合片段在治疗癌症患者中的用途;单克隆抗体在治疗患有癌症的受试者中的用途;包含agr2结合抗体的组合物;包含c4.4a结合抗体的组合物;包含agr2结合抗体和c4.4a结合抗体的组合物;包含抗体的组合物;使用agr2结合抗体;使用c4.4a结合抗体;抗体的使用;和包含抗体的试剂盒